Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study

PURPOSE: Non-small cell lung cancer (NSCLC) patients with EGFR mutation are suffering from a high incidence of brain metastasis (BM). It is still controversial whether cranial radiotherapy could be delayed when the EGFR-tyrosine kinase inhibitors (TKIs) used as first-line therapy for EGFR-positive p...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Ning, Wang, Haoyi, Li, Ji, Zhai, Xiaoyang, Jing, Wang, Jia, Wenxiao, Kong, Li, Zhu, Hui, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790348/
https://www.ncbi.nlm.nih.gov/pubmed/31632080
http://dx.doi.org/10.2147/OTT.S223216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790348/
https://www.ncbi.nlm.nih.gov/pubmed/31632080
http://dx.doi.org/10.2147/OTT.S223216

Ejemplares similares